Correction: Relationship between working hours and power of attention, memory, fatigue, depression and self-efficacy one year after diagnosis of clinically isolated syndrome and relapsing remitting multiple sclerosis (PLoS ONE (2014) 9, 5 (e96444) DOI: 10.1371/journal.pone.0096444);Relationship between working hours and power of attention, memory, fatigue, depression and self-efficacy one year after diagnosis of clinically isolated syndrome and relapsing remitting multiple sclerosis

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Jongen, Peter Joseph ^a   Wesnes, Keith ^b,c   Van Geel, Björn ^d   Pop, Paul ^e   Sanders, Evert ^f   Schrijver, Hans ^g   Visser, Leo H ^h   Gilhuis, H Jacobus ⁱ   Sinnige, Ludovicus G ^j   Brands, Augustina M ^k,l  

^a MS4 Research Institute   (Netherlands)

^b Bracket   (United Kingdom)

^c SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^d Medical Centre Alkmaar   (Netherlands)

^e VieCurie Medisch Centrum   (Netherlands)

^f AMPHIA HOSPITAL   (Netherlands)

^g Westfriesgasthuis   (Netherlands)

^h Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

ⁱ REINIER DE GRAAF HOSPITAL   (Netherlands)

^j MEDICAL CENTER LEEUWARDEN   (Netherlands)

^k UTRECHT UNIVERSITY   (Netherlands)

^l Zuwe Hofpoort Ziekenhuis   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; DEMYELINATING DISEASE; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; EPISODIC MEMORY; FATIGUE; FEMALE; HUMAN; MALE; MEMORY; MULTIPLE SCLEROSIS; PILOT STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SELF CONCEPT; SELF REPORT; SOCIAL STATUS; WORK CAPACITY; WORKING MEMORY; WORKING TIME; CLINICAL TRIAL; DEMYELINATING DISEASES; MIDDLE AGED; MULTICENTER STUDY; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGY; SICKNESS IMPACT PROFILE; YOUNG ADULT;

ADULT; ATTENTION; DEMYELINATING DISEASES; DEPRESSION; FATIGUE; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PILOT PROJECTS; PROSPECTIVE STUDIES; SELF EFFICACY; SICKNESS IMPACT PROFILE; YOUNG ADULT;

EID: 84900325492     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105654     Document Type: Erratum

References (49)

1. Jongen PJ, Ter Horst AT, Brands AM (2012) Cognitive impairment in multiple sclerosis. Minerva Med 103: 73-96.
2. Prakash RS, Snook EM, Lewis JM, Motl RW, Kramer AF (2008) Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis. Mult Scler 14: 1250-1261.
3. Reuter F, Zaaraoui W, Crespy L, Faivre A, Rico A, et al. (2011) Cognitive impairment at the onset of multiple sclerosis: relationship to lesion location. Mult Scler 17: 755-758.
4. Khalil M, Enzinger C, Langkammer C, Petrovic K, Loitfelder M, et al. (2011) Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome. Mult Scler 17: 173-180.
5. Amato MP, Portaccio E, Goretti B, Zipoli V, Iudice A, et al. (2010) Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study. Mult Scler 16: 1474-1482.
6. Jonsson A, Andresen J, Storr L, Tscherning T, Soelberg Sorensen P, et al. (2006) Cognitive impairment in newly diagnosed multiple sclerosis patients: a 4-year follow-up study. J Neurol Sci 245: 77-85. (Pubitemid 43792409)
7. Julian LJ, Vella L, Vollmer T, Hadjimichael O, Mohr DC (2008) Employment in multiple sclerosis. Exiting and re-entering the work force. J Neurol 255: 1354-1360.
8. Amato MP, Ponziani G, Siracusa G, Sorbi S (2001) Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 58: 1602-1606. (Pubitemid 32963224)
9. Morrow SA, Drake A, Zivadinov R, Munschauer F, Weinstock-Guttman B, et al. (2010) Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline. Clin Neuropsychol 24: 1131-1145.
10. Karanikolos M, Mladovsky P, Cylus J, Thomson S, Basu S, et al. (2013) Financial crisis, austerity, and health in Europe. Lancet 381: 1323-1331.
11. Sport MoHWa Dutch Medical Research Involving Human Subjects Act (WMO). International Publication Series Health, Welfare and Sport: 1-34.
12. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58: 840-846. (Pubitemid 41746873)
13. Wesnes KA, McKeith I, Edgar C, Emre M, Lane R (2005) Benefits of rivastigmine on attention in dementia associated with Parkinson disease. Neurology 65: 1654-1656. (Pubitemid 41689487)
14. Wesnes KA, Edgar C, Dean AD, Wroe SJ (2009) The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy. Epilepsy Behav 14: 522-528.
15. Edgar C, Jongen PJ, Sanders E, Sindic C, Goffette S, et al. (2011) Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery. BMC Neurol 11: 68.
16. Wesnes KA, Ward T, McGinty A, Petrini O (2000) The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology (Berl) 152: 353-361.
17. Kraaykamp G (2012) Employment status and family role attitudes: A trend analysis for the Netherlands. International Sociology 27: 21.
18. Siepman TA, Janssens AC, de Koning I, Polman CH, Boringa JB, et al. (2008) The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis. J Neurol 255: 910-916.
19. Ritvo PG FJ, Miller D, Andrews H, Paty DW, LaRocca NG (1997) Multiple Sclerosis Quality of Life Inventory (MSQLI): a user's manual: National Multiple Sclerosis Society.
20. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, et al. (1994) Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 18 Suppl 1: S79-83. (Pubitemid 24023890)
21. Beck AT, Rial WY, Rickels K (1974) Short form of depression inventory: cross-validation. Psychol Rep 34: 1184-1186.
22. Moran PJ, Mohr DC (2005) The validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis. J Behav Med 28: 35-41. (Pubitemid 40543869)
23. Schwartz CE, Coulthard-Morris L, Zeng Q, Retzlaff P (1996) Measuring self-efficacy in people with multiple sclerosis: a validation study. Arch Phys Med Rehabil 77: 394-398. (Pubitemid 26111758)
24. Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A (2001) The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 124: 962-973. (Pubitemid 32458508)
25. Riazi A, Hobart JC, Lamping DL, Fitzpatrick R, Thompson AJ (2002) Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. J Neurol Neurosurg Psychiatry 73: 701-704. (Pubitemid 35448855)
26. McGuigan C, Hutchinson M (2004) The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure. J Neurol Neurosurg Psychiatry 75: 266-269. (Pubitemid 38183536)
27. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452.
28. Zhang J, Waubant E, Cutter G, Wolinsky JS, Glanzman R (2012) EDSS variability before randomization may limit treatment discovery in primary progressive MS. Mult Scler.
29. Ford HL, Gerry E, Tennant A, Whalley D, Haigh R, et al. (2001) Developing a disease-specific quality of life measure for people with multiple sclerosis. Clin Rehabil 15: 247-258. (Pubitemid 32475720)
30. Ford HL, Gerry E, Johnson MH, Tennant A (2001) Health status and quality of life of people with multiple sclerosis. Disabil Rehabil 23: 516-521. (Pubitemid 32591124)
31. Perneger TV (1998) What's wrong with Bonferroni adjustments. BMJ 316: 1236-1238.
32. Rothman KJ (1990) No adjustments are needed for multiple comparisons. Epidemiology 1: 43-46.
33. Schulz D, Kopp B, Kunkel A, Faiss JH (2006) Cognition in the early stage of multiple sclerosis. J Neurol 253: 1002-1010. (Pubitemid 44441123)
34. Glanz BI, Healy BC, Hviid LE, Chitnis T, Weiner HL (2012) Cognitive deterioration in patients with early multiple sclerosis: a 5-year study. J Neurol Neurosurg Psychiatry 83: 38-43.
35. Bonnet MC, Allard M, Dilharreguy B, Deloire M, Petry KG, et al. (2010) Cognitive compensation failure in multiple sclerosis. Neurology 75: 1241-1248.
36. Smith MM, Arnett PA (2005) Factors related to employment status changes in individuals with multiple sclerosis. Mult Scler 11: 602-609. (Pubitemid 41387707)
37. Flensner G, Landtblom AM, Soderhamn O, Ek AC (2013) Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study. BMC Public Health 13: 224.
38. Kern S, Kuhn M, Ziemssen T (2013) [Chronically ill and unemployed? A review on vocational status in multiple sclerosis]. Fortschr Neurol Psychiatr 81: 95-103.
39. Pompeii LA, Moon SD, McCrory DC (2005) Measures of physical and cognitive function and work status among individuals with multiple sclerosis: a review of the literature. J Occup Rehabil 15: 69-84. (Pubitemid 40558526)
40. Ghaffar O, Fiati M, Feinstein A (2012) Occupational attainment as a marker of cognitive reserve in multiple sclerosis. PLoS One 7: e47206.
41. Kraemer M, Herold M, Uekermann J, Kis B, Wiltfang J, et al. (2012) Theory of mind and empathy in patients at an early stage of relapsing remitting multiple sclerosis. Clin Neurol Neurosurg 115: 1016-1022.
42. Pottgen J, Dziobek I, Reh S, Heesen C, Gold SM (2013) Impaired social cognition in multiple sclerosis. J Neurol Neurosurg Psychiatry 84: 523-528.
43. Kraemer M, Herold M, Uekermann J, Kis B, Daum I, et al. (2013) Perception of affective prosody in patients at an early stage of relapsing-remitting multiple sclerosis. J Neuropsychol 7: 91-106.
44. Baumstarck K, Reuter F, Boucekine M, Aghababian V, Klemina I, et al. (2012) Relevance of quality of life assessment for multiple sclerosis patients with memory impairment. PLoS One 7: e50056.
45. Benedict RH, Duquin JA, Jurgensen S, Rudick RA, Feitcher J, et al. (2008) Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire. Mult Scler 14: 940-946.
46. Freedman MS, Comi G, De Stefano N, Barkhof F, Polman CH, et al. (2014) Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice. Multiple Sclerosis and Related Disorders 3: 147-155.
47. Hankomaki E, Multanen J, Kinnunen E, Hamalainen P (2013) The progress of cognitive decline in newly diagnosed MS patients. Acta Neurol Scand 129: 184-91.
48. Stuckler D, Basu S, McKee M (2010) How government spending cuts put lives at risk. Nature 465: 289.
49. Stuckler D, Basu S, McKee M, Suhrcke M (2010) Responding to the economic crisis: a primer for public health professionals. J Public Health (Oxf) 32: 298-306.